The use of genomic evidence in cancer cases is now commonplace, including both talc and traditional asbestos cases. However, the list of relevant genes goes far beyond BAP1 or any other single gene mutation.

On Tuesday, October 30, 2018, ToxicoGenomica offered a complimentary webinar educating defense attorneys on the use of genomics in toxic tort cases.

You can view a recording of the webinar below and a copy of the slides are available toward the bottom of this post.

The webinar provided defense counsel and clients with an opportunity to develop an understanding of the use of genomic evidence by both plaintiffs and defendants, and new scientific findings that associate many inherited mutations with the development of mesotheliomas and/or ovarian cancers. The webinar is intended for defense lawyers  and clients who want to understand the tactics used by some plaintiffs, and those who wish to use fact based quantitative science in defending asbestos or talc cases.

ToxicoGenomica team members discussed a variety of topics that provided valuable insights to lawyers, including:

• Genomics primer specifically for traditional asbestos cancer cases or talc cases
• Specific update on the use of genomics in talc and traditional asbestos trials
• Examples of recent use and misuse of genetics in the courtroom including uses of susceptibility vs. predisposition
• Development of targeted gene panels that substantially reduce expenses

Webinar Presenters:

Dr. Len Van Zyl, Ph.D. – world recognized leader in genomics research and discovering the source of diseases

Kirk Hartley, J.D. – defense and plaintiff lawyer highly experienced in the legal application of genomics to toxic tort cases